Prognostic DNA Methylation Markers for Prostate Cancer

por Strand, Siri H., Orntoft, Torben F., Sorensen, Karina D.
Publicado 2014

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

por Storebjerg, Tine Maj, Strand, Siri H., Høyer, Søren, Lynnerup, Anne-Sofie, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

por Haldrup, Christa, Pedersen, Anne L., Øgaard, Nadia, Strand, Siri H., Høyer, Søren, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer

por Strand, Siri H., Hoyer, Soren, Lynnerup, Anne-Sofie, Haldrup, Christa, Storebjerg, Tine Maj, Borre, Michael, Orntoft, Torben F., Sorensen, Karina D.
Publicado 2015

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases

por Schmidt, Linnéa, Møller, Mia, Haldrup, Christa, Strand, Siri H., Vang, Søren, Hedegaard, Jakob, Høyer, Søren, Borre, Michael, Ørntoft, Torben, Sørensen, Karina Dalsgaard
Publicado 2018

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors

por Kristensen, Gitte, Strand, Siri H., Røder, Martin Andreas, Berg, Kasper Drimer, Toft, Birgitte Grønkær, Høyer, Søren, Borre, Michael, Sørensen, Karina Dalsgaard, Brasso, Klaus
Publicado 2019

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer

por Bjerre, Marianne T., Strand, Siri H., Nørgaard, Maibritt, Kristensen, Helle, Rasmussen, Anne KI, Mortensen, Martin Mørck, Fredsøe, Jacob, Mouritzen, Peter, Ulhøi, Benedicte, Ørntoft, Torben, Borre, Michael, Sørensen, Karina D.
Publicado 2019

Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome

por Strand, Siri H., Schmidt, Linnéa, Weiss, Simone, Borre, Michael, Kristensen, Helle, Rasmussen, Anne Karin Ildor, Daugaard, Tina Fuglsang, Kristensen, Gitte, Stroomberg, Hein Vincent, Røder, Martin Andreas, Brasso, Klaus, Mouritzen, Peter, Sørensen, Karina Dalsgaard
Publicado 2020

RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy

por Strand, Siri H., Switnicki, Michal, Moller, Mia, Haldrup, Christa, Storebjerg, Tine M., Hedegaard, Jakob, Nordentoft, Iver, Hoyer, Soren, Borre, Michael, Pedersen, Jakob S., Wild, Peter J., Park, Jong Y., Orntoft, Torben F., Sorensen, Karina D.
Publicado 2016

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential

por Bjerre, Marianne Trier, Nørgaard, Maibritt, Larsen, Ole Halfdan, Jensen, Sarah Østrup, Strand, Siri H., Østergren, Peter, Fode, Mikkel, Fredsøe, Jacob, Ulhøi, Benedicte Parm, Mortensen, Martin Mørck, Jensen, Jørgen Bjerggaard, Borre, Michael, Sørensen, Karina D.
Publicado 2020

Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors

por Llinàs-Arias, Pere, Ensenyat-Mendez, Miquel, Íñiguez-Muñoz, Sandra, Orozco, Javier I. J., Valdez, Betsy, Salomon, Matthew P., Matsuba, Chikako, Solivellas-Pieras, Maria, Bedoya-López, Andrés F., Sesé, Borja, Mezger, Anja, Ormestad, Mattias, Unzueta, Fernando, Strand, Siri H., Boiko, Alexander D., Hwang, E Shelley, Cortés, Javier, DiNome, Maggie L., Esteller, Manel, Lupien, Mathieu, Marzese, Diego M.
Publicado 2023

Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma

por Risom, Tyler, Glass, David R., Averbukh, Inna, Liu, Candace C., Baranski, Alex, Kagel, Adam, McCaffrey, Erin F., Greenwald, Noah F., Rivero-Gutiérrez, Belén, Strand, Siri H., Varma, Sushama, Kong, Alex, Keren, Leeat, Srivastava, Sucheta, Zhu, Chunfang, Khair, Zumana, Veis, Deborah J., Deschryver, Katherine, Vennam, Sujay, Maley, Carlo, Hwang, E. Shelley, Marks, Jeffrey R., Bendall, Sean C., Colditz, Graham A., West, Robert B., Angelo, Michael
Publicado 2022

HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

por Ross-Adams, Helen, Ball, Stephen, Lawrenson, Kate, Halim, Silvia, Russell, Roslin, Wells, Claire, Strand, Siri H., Ørntoft, Torben F., Larson, Melissa, Armasu, Sebastian, Massie, Charles E., Asim, Mohammad, Mortensen, Martin M., Borre, Michael, Woodfine, Kathryn, Warren, Anne Y., Lamb, Alastair D., Kay, Jonathan, Whitaker, Hayley, Ramos-Montoya, Antonio, Murrell, Adele, Sørensen, Karina D., Fridley, Brooke L., Goode, Ellen L., Gayther, Simon A., Masters, John, Neal, David E., Mills, Ian G.
Publicado 2016

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

por Strand, Siri H., Rivero-Gutiérrez, Belén, Houlahan, Kathleen E., Seoane, Jose A., King, Lorraine M., Risom, Tyler, Simpson, Lunden A., Vennam, Sujay, Khan, Aziz, Cisneros, Luis, Hardman, Timothy, Harmon, Bryan, Couch, Fergus, Gallagher, Kristalyn, Kilgore, Mark, We, Shi, DeMichele, Angela, King, Tari, McAuliffe, Priscilla F., Nangia, Julie, Lee, Joanna, Tseng, Jennifer, Storniolo, Anna Maria, Thompson, Alastair M., Gupta, Gaorav P., Burns, Robyn, Veis, Deborah J., DeSchryver, Katherine, Zhu, Chunfang, Matusiak, Magdalena, Wang, Jason, Zhu, Shirley X., Tappenden, Jen, Ding, Daisy Yi, Zhang, Dadong, Luo, Jingqin, Jiang, Shu, Varma, Sushama, Anderson, Lauren, Straub, Cody, Srivastava, Sucheta, Curtis, Christina, Tibshirani, Rob, Angelo, Robert Michael, Hall, Allison, Owzar, Kouros, Polyak, Kornelia, Maley, Carlo, Marks, Jeffrey R., Colditz, Graham A., Shelley Hwang, E., West, Robert B.
Publicado 2023